His-TT-B7-H1lgV

N/A

Report date: 2025/03/20 15:19:45

Base Information

Drug NameHis-TT-B7-H1lgV
Drug Alias NameHis-TT-B7-H1lgV vaccine (State Key Laboratory of Cancer Biology/Fourth Military Medical University)PD-L1 checkpoint inhibitor-inducing vaccine (State Key Laboratory of Cancer Biology/Fourth Military Medical University)PD-L1-targeting vaccine (State Key Laboratory of Cancer Biology/Fourth Military Medical University)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesState Key Laboratory Of Cancer Biology
China Registration ClassN/A

Develop Information

Active CompaniesState Key Laboratory Of Cancer BiologyAir Force Medical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A